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             INTRODUCION 
 
Pleural effusion is an abnormal accumulation of fluid in the Pleural space. The 
pleural space lies between the lung and chest wall and normally contains a very thin 
layer of fluid, which serves as a coupling system. Excess fluid results from the 
disruption of the equilibrium that exists across pleural membranes. Pleural effusion is 
an indicator of a pathologic process that may be of primary pulmonary origin or of an 
origin related to another organ system or occasionally the first evidence of some other 
systemic disease.  
It may occur in the setting of acute or chronic disease and is not a diagnosis in 
itself. Diagnosing the etiology of pleural effusions clinically with certainty is a 
challenging task for physicians. 
The advancements in the field of medicine and  with the advent of  various 
diagnostic aids like pleural fluid analysis, pleural fluid cytology, pleural biopsy, 
ultrasonography, bronchoscopy, biopsy of scalene lymph node, serological tests like 
ANA, ADA, Rheumatoid factor, Pleural fluid Amylase, CT thorax help the physician 
to arrive at the diagnosis at an earlier course of the disease. 
Here I have made an attempt to arrive at the etiological diagnosis of 100 cases 
of pleural effusion by collecting relevant clinical as well as laboratory data using the 
recent modalities available in our hospital. 
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AIM OF THE STUDY 
 
1. To study about the clinical presentation of various causes of pleural effusions. 
 
2. To identify the spectrum of pleural effusion in 100 cases of pleural effusion 
admitted in Govt.S.M.C.H   between 2007-2008. 
 
3. To study about the rare causes of pleural effusion in our hospital. 
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REVIEW OF LITERTURE 
 
DEFINITION:   
 Pleural effusion is the result of accumulation of fluid in the pleural space, is a 
common medical problem.1   They can be caused by several mechanisms including 
increased permeability of the pleural membrane, increased pulmonary capillary 
pressure, decreased negative intrapleural pressure, decreased oncotic pressure, and 
obstructed lymphatic flow.  Pleural effusion indicates the presence of disease which 
may be pulmonary, pleural or extra pulmonary.  
In the course of embryonic development the pleural membrane is formed from 
mesenchyme to line the space that will separate the lungs from mediastinum, 
diaphragm and chest wall.1 
 
NORMAL COMPOSITION OF PLEURAL FLUID 2 
                Volume                                            -                   0.1-0.2 ml/Kg 
                Cells/cmm                                        -                   1000-5000 
                Mesothelial cells                              -                    3 – 70 % 
                Macrophages                                   -                    30 –75%  
                Lymphocytes                                  -                     2 – 30%  
                Granulocytes                                   -                    10 % 
                Protein                                             -                    1 – 2 g/ dL 
               % Albumin                                       -                    ~ plasma level 
                Glucose                                           -                    ~ plasma level 
                LDH                                                -                    < 50% of plasma level 
                Ph                                                    -                    7.60-7.64        
4 
 
s 
ANATOMY OF THE PLEURA: 3, 4  
  
Each Lung is invested by a delicate serous membrane which is arranged in the 
form of a closed invaginated sac and is termed the pleura. The portion that covers the 
surface of lung and lines the tissues in-between the lobes is called the visceral pleura. 
The rest of the membrane lining the inner half of the chest wall is reflected over the 
structures occupying the middle part of the thorax is termed the parietal pleura. The 
visceral and parietal pleura are continuous with each other around and below the root 
of the lung. In healthy they are in actual contact with each other in all phases of 
respiration. The potential space between them is called the Pleural cavity. 
The right pleural cavity is wider than the left because the heart extends further 
to the left than to the right. The pleura cover the apices of the lung one inch above the 
medial third of the clavicle. The anterior margin found to converge, as they pass 
behind the sternoclavicular joints and come into apposition at the lower border of the 
manubrium sterni. It may be noticed that the anterior margin remains in apposition up 
to the level of the 4th costal cartilage. Right Pleura continues vertically, but the left 
arches out and descend lateral to the border of the sternum, half way to the apex of the 
heart. Each turn laterally at the 6th costal cartilage and passes around the chest wall 
crossing the midclavicular line at 8th rib and the mid axillary line at 10th rib. This 
lower border forms the costophrenic recess, falls somewhat short of the costal margin. 
It crosses the 12th rib at the lower border of the sacrospinalis muscle and passes in 
horizontally to the lower border of the 12th thoracic vertebra.  
The arterial supply and lymphatic drainage of the parietal pleura are 
intercostals, internal thoracic and musculophrenic arteries and nodes respectively. The 
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nerve supply is from the intercostals and phrenic nerves. The arterial supply of the 
visceral pleura is by the branches of Pulmonary arteries and the capillaries drain into 
both systemic and pulmonary venous system. Its lymphatics join with those of the 
lung and the nerve supply is derived from the autonomic system. It is insensitive to 
sensory stimuli. 
 
PHYSIOLOGY OF PLEURA: 2  
     
FIG 1.  Distribution of Hydrostatic (P) and Oncotic (H) pressure across the 
parietal and visceral pleura. The numbers in the open arrow indicate the net 
magnitude of pressure gradient between the hydrostatic and oncotic pressure 
across the visceral and parietal pleura. 
   
       During normal inspiration there is negative pressure in relation to the 
atmosphere (about -0.66kpa at functional residual capacity) within the pleural space.2,5  
This would tend to suck capillary fluid and gas from the surrounding tissue into the 
space. The pleura transmits the force generated by the respiratory muscles of the 
lung.6  There is a regular transfer of low protein fluid from parietal to pleural space. 
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Protein and particles are turned over much less rapidly, being absorbed by lymphatics 
opening into the parietal pleura.5, 7, 8, and 9 
 Pleural surface pressure increased approximately 0.5cms of H2O of vertical 
distance from the apex to the base of the lung6. The pleural fluid is in a dynamic state 
30-75% of water being turned over every hour on normal respiration.7,8 
 Pleural space is lubricated by a thin film of few milliliters of serous fluid. For 
this lubrication surfactant would be more effective, have been identified in the 
fluid.9,10  
 
PATHOPHYSIOLOGY: 11 
 Normal interstitial fluid is filtered from the arterial end of the capillary, up to 
90% is absorbed at the venous end of the capillary bed and the rest is removed by the 
lymphatics. Three main factors involved in the fluid movement are:  
1. Capillary permeability 
2. Hydrostatic pressure 
3. Colloid osmotic pressure 
The potential pleural space has very close proximity to both the systemic and 
pulmonary circulation. Thus, the parietal pleura is supplied by the systemic circulation 
via the intercostals arteries and its venous drainage is mainly through the azygous 
system into superior venacava. In contrast, the arterial supply of the visceral pleura is 
by branches of the pulmonary artery and their capillaries drain into both systemic and 
pulmonary venous system. The intravascular hydrostatic pressure within the venous 
end of the visceral pleural capillaries is less than hydrostatic pressure in the capillaries 
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of parietal pleura. Thus considering the pleural surfaces in isolation, the two separate 
circulatory system could presumably cope with filtrate, however, because of their 
closer proximity the visceral pleura is able to apply a sucking force to the pleural 
space which not only keep the later virtually free of fluid but also keeps the visceral 
and parietal surfaces apposed against the forces of lung elastic recoil inwards and 
chest wall outwards. 
The visceral pleural capillary bed has a large capacity to absorb protein-free 
fluid. Protein removal is by the lymphatic system. Normally, the pleural space 
contains small amount of fluid in protein content but in pleural effusion the later is 
increased. However, the capacity of the lymphatic system to deal with protein is small. 
The factors affecting the pleural fluid transport system have been reviewed in 
detail by Brook (1972). When equilibrium between formation and absorption of 
pleural fluid is altered due to either one of the following reasons, abnormal 
accumulation of pleural fluid occurs. 
MECHANISM THAT LEADS TO ACCUMULATION OF PLEURAL FLUID: 11,12 
1. Increased Hydrostatic pressure in the microvascular circulation (CCF) 
2. Decreased Oncotic pressure in the microvascular circulation 
(Hypoalbuminemia) 
3. Decreased pressure in the pleural space (complete Lung collapse) 
4. Increased permeability of the pleural membrane (Inflammatory process) 
5. Decreased Lymphatic drainage from the pleural space (Malignancy) 
6. Movement of fluid from the peritoneum (Ascites) 
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Small pleural tumor implants are common findings. Such metastatic deposits 
can cause capillary and lymphatic obstruction resulting in increased pleural fluid 
production and decreased resorption. In addition secondary infections associated with 
the tumor deposits results in further inflammation and increased capillary 
permeability. Occasionally erosion of small vessels by tumor implants may cause 
hemorrhage into pleural space. 
Major mediastinal lymph node involvement, which occurs commonly in 
conditions like lymphoma and small cell carcinoma of the bronchus, may interfere 
with lymphatic drainage and results in pleural effusion with negative cytology. Protein 
is unable to enter the vascular space and causes increase in pleural osmotic pressure 
and secondary accumulation of fluid. Obstruction of the superior venacava occurs 
with bronchial carcinoma and lymphoma elevates the systemic venous pressure 
causing a decrease in parietal pleural resorption and lymphatic flow. 
 
PATHOGENESIS OF EFFUSION IN VARIOUS DISEASES: 2, 13 
 Primary pathologic involvement of pleura is very rare. Primary disorders that 
reasonably common are: 
1. Primary intrapleural bacterial infection that imply seeding of space as an 
isolated focus in the course of a transient bacteremia. 
2. A primary neoplasm of the pleura, a mesothelioma.                                             
 Except these exceptions, usually pleural disease follows some underlying 
disorder, most often pulmonary and usually the pleural involvement is only an 
inconspicuous feature of the primary process. Secondary infections are extremely 
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common, occasionally: secondary pleural disease assumes a dominant role in the 
clinical problem, as occurs in bacterial pneumonia, with development of empyema. 
The disease of the pleura can be divided into:11 
a. Inflammatory  
b. Non-inflammatory 
INFLAMMATION: 
 Inflammation of the pleura can be divided according to the character of 
resultant exudates into serous, fibrinous, serofibrinous, suppurative and hemorrhagic 
pleuritis. 
 Serous, fibrinous, serofibrinous essentially caused by the same process but the 
amount of fibrinous component depends largely on the stage and severity of 
inflammation. Common causes within the lungs are Tuberculosis, Pneumonia, 
Pulmonary infarction, Lung abscess, Bronchiectasis, Rheumatic fever, Disseminated 
lupus erythematosis, Uremia, systemic infections like Typhoid fever, Tularemia, 
Ornithosis, Blastomycosis, Coccidiodomycosis. The pleura is almost invariably 
affected by tuberculosis and the pleural reaction in the early stage tends to remain as a 
serous or copious serofibrinous exudation, commonly designated as pleurisy with 
effusion. Radiation used in therapy for tumors of lung or mediastinum often causes a 
serofibrinous exudates. 
Suppurative Pleuritis is designated as frank, purulent exudates usually imply 
bacterial or mycotic seeding of the pleural space.  Rarely, suppurative infection of the 
pleura leads on to fibrosis and markedly affects the lung expansion. Calcification can 
occur. Massive calcification is a feature of tuberculous empyema. 
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 Hemorrhagic pleuritic exudates are infrequent and are usually found only in 
hemorrhagic diathesis, rickettsial   disease, malignancy and very rarely in tuberculosis. 
NON INFLAMMATORY PLEURAL COLLECTION:  
 Hydrothorax is a non-inflammatory collection of serous fluid within the pleural 
cavity. Hydrothorax may be unilateral or bilateral depending upon the underlying 
cause. The most common cause of hydrothorax is Congestive cardiac failure. 
Other conditions that produce transudative effusion are: 
1. Renal failure 
2. Liver disease, particularly cirrhosis of liver with ascites. It is generally believed 
that the fluid reaches the pleural cavity via the transdiaphragmatic lymphatics. 
3. Meig’s Syndrome-Ovarian tumor (fibroma) with ascites and right sided hydro 
thorax. It is now studied that any type of ovarian tumor may cause this 
syndrome.  
If the underlying cause is alleviated the hydrothorax get reabsorbed completely. 
Hemothorax is the escape of blood into the pleural cavity. It is almost invariably a 
fatal complication of aortic aneurysm or a vascular trauma. Rarely non fatal leakage of 
smaller amounts can provide a stimulus to organization and pleural adhesions. 
Chylothorax designates an accumulation of milky fluid, usually of lymphatic 
origin; chyle is milky white because it contains finely emulsified fat which should be 
differentiated from turbid serous fluid. It is most often encountered in malignancies 
arising within the thoracic cavity, which often cause obstruction to the major 
lymphatic ducts. However, more distant cancer metastasizes via the lymphatics and 
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grows within the thoracic duct causing obstruction and resulting in chylothorax. Less 
commonly it may accompany traumatic rupture or perforation of the thoracic duct. 
 
CAUSES OF PLEURAL EFFUSION: 
 Pleural effusions are classified into transudates and exudates. A transudative 
pleural effusion occurs when the balance of hydrostatic forces influencing the 
formation and resorption of the pleural fluid is altered to favour pleural fluid 
accumulation. The permeability of the capillaries is normal.14 In contrast, an exudative 
pleural effusion develops when the pleural surface and/or the local capillary 
permeability are altered.15  
ETIOLOGY16 
Transudate: 
A. Increased Hydrostatic pressure: 
• Left ventricular failure 
B. Decreased Osmotic pressure: 
• Liver cirrhosis 
• Hypoalbuminemia 
• Peritoneal dialysis 
• Hypothyroidism 
• Nephrotic syndrome 
• Mitral stenosis 
• Pulmonary embolism 
• Constrictive pericarditis 
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• Urinothorax 
• Superior venacaval obstruction 
Exudate: 
A. Inflammatory conditions of the pleura: 
• Tuberculosis 
• Parapneumonic effusion(bacterial, viral, parasitic, fungus) 
• Pulmonary infections  
• Pulmonary embolism 
Collagen vascular diseases: 
• Rheumatoid arthritis 
• Autoimmune diseases (SLE) 
• Immunoblastic lymphadenopathy 
• Sjogren’s syndrome 
• Wegener’s granulomatosis 
• Churg-Strauss syndrome 
Disorders of contiguous structures: 
• Esophageal rupture 
• Diaphragmatic hernia 
• Liver abscess 
• Subphrenic abscess 
• Pancreatitis 
• Endoscopic variceal Sclerotherapy 
• After Liver Transplant 
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Malignancy: 
• Mesothelioma 
• Malignancy of lung, breast, ovary. (Primary and metastatic disease) 
Rare Causes: 
• Post Myocardial infarction syndrome 
• Meig’s Syndrome 
• Yellow nail syndrome 
• Benign asbestos effusion 
• Uremia 
• Post radiation therapy 
• Sarcoidosis 
• Trapped Lung 
• Radiation therapy 
• Post-coronary artery bypass surgery 
• Ovarian hyperstimulation syndrome 
Drugs known to cause Pleural effusion: 
• Amiodarone 
• Nitrofurantoin 
• Methotrexate 
• Methysergide 
• Practolol 
• Dantrolene 
• Procarbazine 
14 
 
s 
• Procainamide 
• Penicillamine 
• GCSF 
• Cyclophosphamide 
• Bromocriptine 
Mycobacterium Tuberculosis and Pleural effusion: 17 
Character of the fluid: 
 Serous exudates, very rarely Hemorrhagic. 
Pathogenesis: 
 Most of the cases it spreads from underlying pulmonary focus. The effusion is 
always in the side of pulmonary lesion. Sometimes pleural effusion may be due to 
rupture of sub pleural focus or pleural involvement in Milliary tuberculosis. 
Clinical Features: 
 **1/3rd of patients will have acute illness less than one week duration. 
 **2/3rd seek medical attention within a month, after the onset of symptoms. 
 **common symptoms are - Non Productive cough, Pleuritic type of chest pain, 
Fever – in 50% cases. Patients with chronic illness will have loss of weight, appetite, 
malaise and dyspnoea. 
 Tuberculous effusion is usually moderate and unilateral. In 1/3rd of patients 
tuberculous effusion will have co-existing parenchymal disease which is evident 
radiologically. 30% of patients with Tuberculous effusion will have negative 
tuberculin test. It will become positive after 8 weeks of development of symptoms. 
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Mycobacterium is demonstrable in pleural fluid only in 10% cases. Culture will 
be positive in 25% cases. 50% cells in pleural fluid is mature lymphocytes. Eosinophil 
count rarely exceeds 10%. 
HIV Infection: 16 
 Pleural effusions are uncommon in such patients. The most common cause is 
Kaposi’s sarcoma. Followed by parapneumonic effusion. Other common causes are 
tuberculosis, cryptococcosis and primary effusion lymphoma. Pleural effusions are 
very uncommon with Pneumocystis carnii infection. A pleural effusion is seen in 7-27 
% of hospitalized patients with HIV infection 
Pancreatitis: 2  
 Usually serous exudates but may be serosanguinous. Pleural fluid amylase 
levels are higher than serum. Normal glucose, leucocytes 1000-50,000 cells/cmm, 
predominant polymorphs and rarely eosinophils are the characteristic feature of a 
pancreatic effusion in pleural fluid. Patients presents with history of acute abdominal 
pain, nausea, vomiting, rarely chest pain and dyspnoea. Usually pancreatic effusion is 
painless. 20% of patients with acute pancreatitis develop Pleural effusion, usually left 
sided sometimes bilateral occasionally right sided. Contact of the pleura with enzyme 
rich peripancreatic fluid occurs through the transdiaphragmatic lymphatics and less 
commonly through sinus between pancreatic pseudocyst and pleural space. 
 Diagnosis of pancreatic disease complications can be done by the pleural fluid 
pancreatic enzyme activity, and by computed tomography, Ultrasonography, 
Endoscopic Retrograde Cholangiopancreatography (ERCP). 
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Neoplasms: 
 Malignant pleural effusions secondary to metastatic disease are the second 
most common type of exudative pleural effusion. These are the commonest cause of 
exudative effusion more than 60 years of age. The three tumors that cause 
approximately 75% of all malignant pleural effusions are lung carcinoma, breast 
carcinoma, and lymphoma.16  Others include spread from liver metastasis, rarely an 
Ovarian or a gastric cancer. 7% cases show  unknown primary. Mediastinal invasion 
with lymphatic blockage presenting with effusion is suggestive of Hodgkin’s 
Lymphoma.  Very rarely few cases of Multiple myeloma presenting as bilateral 
pleural effusion have also been noticed. It is usually a late complication and is 
associated with a poor prognosis.18  
  Most patients complain of dyspnoea, which is frequently out of proportion to 
the size of the effusion. The exudates may be serous, serosanguinous or hemorrhagic. 
Obstructive Pneumonitis with pleural effusion have a very strong presumptive 
evidence per se for diagnosis. Recovery of cells from pleural fluid or sputum, positive 
pleural biopsy, Bronchoscopy or Mediastinal node Biopsy, Fine needle aspiration 
cytology (FNAC) of secondary lymph node or from metastatic secondaries is helpful 
in diagnosis. 
Mesothelioma: 16 
Malignant mesotheliomas are primary tumors that arise from the mesothelial 
cells that line the pleural cavities. Most are related to asbestos exposure. Patients with 
mesothelioma present with chest pain and shortness of breath. The chest radiograph 
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reveals a pleural effusion, generalized pleural thickening, and a shrunken hemithorax. 
Thoracoscopy or open pleural biopsy is usually necessary to establish the diagnosis.2  
Parapneumonic effusion:       
 Parapneumonic effusions are associated with bacterial pneumonia, lung abscess 
or bronchiectasis. Patients with aerobic bacterial pneumonia and pleural effusion 
present with an acute febrile illness consisting of chest pain, sputum production, and 
leukocytosis. Patients with anaerobic infections present with a subacute illness with 
weight loss, a brisk leukocytosis, mild anemia, and a history of some factor that 
predisposes them to aspiration. If the free fluid separates the lung from the chest wall 
by more than 10 mm on radiological examinations, a therapeutic thoracentesis should 
be performed.16 The concentration of pleural-fluid myeloperoxidase helps to 
differentiate between nonpurulent complicated and noncomplicated parapneumonic 
pleural effusions.19 Pleural fluid IL-8 is also an accurate marker for the identification 
of non-purulent complicated parapneumonic pleural effusion.20           
 Empyema: 2           
 Refers to a grossly purulent effusion. Clinically features include – High grade 
remittent fever with rigors and weight loss. Pleural Pain associated with cough and 
sputum production. Pleural fluid cytology reveals Polymorphonuclear leucocytosis. 
Organisms resulting in empyema: (75 % - single organisms) Mycobacterium 
tuberculosis, Streptococcus milleri, Streptococcus pneumonia, Staphylococcus aureus, 
E.coli, Klebsiella Proteus, B.melaninogenicus, Fusobacterium, Candida.21  25% 
multiple organisms: Streptococcus milleri and anareobes. 
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Pulmonary Embolization:  
 One of the rare cause of pleural effusion, which is usually exudative but can be 
transudative. Dyspnea is the most common symptom. The diagnosis is established by 
spiral CT scan or pulmonary arteriography.16 
Effusion due to Heart Failure: 16 
The most common cause of pleural effusion is left ventricular failure. The 
effusion occurs because the increased amounts of fluid in the lung interstitial spaces 
exit in part across the visceral pleura. This overwhelms the capacity of the lymphatics 
in the parietal pleura to remove fluid. A diagnostic thoracentesis should be performed 
if the effusions are not bilateral and comparable in size, if the patient is febrile, or if 
the patient has pleuritic chest pain to verify that the patient has a transudative effusion. 
Otherwise the patient is best treated with diuretics. If the effusion persists despite 
diuretic therapy, a diagnostic thoracentesis should be performed. 
Hepatic Hydrothorax: 16 
Pleural effusions occur in approximately 5% of patients with cirrhosis and 
ascites. The predominant mechanism is by the direct movement of peritoneal fluid 
through small holes in the diaphragm into the pleural space. The effusion is usually 
right-sided and frequently is large enough to produce severe dyspnoea. If medical 
management does not control the ascites and the effusion, the best treatment is a liver 
transplant. If the patient is not a candidate for this, the best alternative is insertion of a 
transjugular intrahepatic portal systemic shunt. 
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CLINICAL FEATURES OF PLEURAL EFFUSION: 
 The onset of symptoms depends upon the quantity of the effusion and the mode 
of onset. Pleuritic pain and dry cough are usually the earliest symptoms but there may 
be preceding period of fever, loss of appetite and loss of weight. If the effusion 
accumulates rapidly dyspnoea, cyanosis and mediastinal flutter may be evident. 
  Pleural effusion may be: Generalised in the pleural space, Loculated in the 
pleural space, Interlobular, Intrapulmonary. 
Pleural effusion can be diagnosed clinically when the pleural is more than 300 
ml and it can be diagnosed radiologically in lateral view when it is 200 ml, in lateral 
decubitus view <200 ml and in PA view 500 – 600 ml. 
 If the effusion is generalised and is sufficiently large, the physical signs are: 
1) Restriction of respiratory movements on the affected side 
2) Stony dullness on percussion 
3) Diminished or absent breath sounds 
4) Diminished or absent vocal resonance and fremitus 
5) Mediastinal displacement to the opposite side >1000 ml 
Massive pleural effusion without mediastinal shift suggests fixation of the 
mediastinum and the following possibilities should be considered: 
a) Carcinoma of the main stem bronchus with atelectasis of the ipsilateral lung  
b) Fixed mediastinum due to neoplastic lymph nodes 
c) Malignant mesothelioma 
At the upper level of the dullness, which sweeps upwards towards axilla, it is said 
that the air conducted through the relaxed or collapsed lung produces tubular 
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breathing, egophony (E- to- A change) and whispering pectoriloquy. Sometimes 
pleural friction rub may also be heard if there is associated pleurisy. With small 
effusion the signs are best elicited at the base posteriorly. Effusion located at the 
fissures may not be detectable on physical examination. Intrapulmonary effusion 
(subpulmonic effusion) may be clinically indistinguishable from fixed elevation of 
hemi–diaphragm with blunting of posterior costo-phrenic angle on lateral chest 
radiograph and other hint to diagnosis is widening of the distance between the top of 
the gastric bubble and the top of the Left hemi-diaphragm (2cms). Also, an effusion 
on the Right side causes the minor fissure to appear close to the diaphragm than usual. 
 
PHYSICAL SIGNS OF PLEURAL EFFUSION 
Amount of 
Effusion 
Expansion Fremitus Percussion Breath 
sounds 
Contralateral 
mediastinal shift
Small N N N Vesicular No 
300-1000ml Decreased Decreased Stony dull Decreased  
Vesicular 
No 
1000-2000ml Moderately 
Decreased 
Decreased Stony dull Moderately 
decreased 
 
 + 
>2000 ml Severely 
Decreased 
Moderately 
Decreased 
Stony dull Severely 
Decreased 
 
 ++ 
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DIAGNOSTIC ALGORITHM FOR INVESTIGATION OF PLEURAL EFFUSION 
      
 
                                                                                                     YES         YES 
 
            
 
 
 
 
        
            
    
 
 
 
 
 
  
 
           
 
 
History, clinical examination and chest radiograph 
Does the clinical picture suggest a 
transudate? LVF,  Hypoalbuminemia,
dialysis.
Treat the cause 
                   Pleural aspiration                                 
Send to cytology, protein, LDH, pH, Gram 
stain, Culture & sensitivity, AFB stain & culture 
Do you suspect Chylothorax,  hemothorax or 
   RESOLVED 
NO 
YES
STOP
Do Pleural 
fluid 
Cholesterol 
Triglycerides, 
Hematocrit, 
centrifuge 
Culture and 
Sensitivity 
YES NO 
    Is it transudate? YES Treat the cause
NO
Has the fluid and chemical analysis     
given the diagnosis 
NO 
Refer to chest physician
Request Contrast enhanced CT-Thorax
Obtain Pleural tissue either by ultrasound/ CT guided Biopsy or by closed Pleural biopsy or 
Thoracoscopy.  Send this for histology and TB culture together with a repeat pleural aspirate for 
cytology, microbiological study:  +/- Complement levels and amylase (in suspected cases)
Cause found Treat appropriately YES NO   Reconsider Thoracoscopy  
NO
Cause found 
Reconsider Pulmonary Embolism and Tuberculosis. 
Wait for diagnosis to evolve 
YES
NO 
      22 Thorax 
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INVESTIGATION OF PLEURAL EFFUSION: 
The initial step in assessing a pleural effusion is to ascertain whether it is a 
transudate or a exudate. The detailed clinical assessment alone is often capable of 
identifying a transudative effusion. Approximately 75% of patients with pulmonary 
embolism and pleural effusion have a history of pleuritic pain. These effusions tend to 
occupy less than a third of the hemithorax and the dyspnoea is often out of proportion 
to its size. The patient drug history is also important. 
 
RADIOLOGY: 
 The most sensitive method of detection of pleural fluid is by roentgenogram. 
PA and Lateral chest radiographs should be taken in suspected pleural effusion. 
 The plain chest radiographic features of pleural effusion are usually 
characteristic. The PA chest radiograph is abnormal in the presence of about 200 ml of 
pleural fluid. However only 50 ml of pleural fluid can produce detectable posterior 
costophrenic angle blunting on a lateral chest radiograph23. Lateral decubitus film is 
occasionally useful as the free fluid gravitates to the most dependant part of the chest 
wall differentiating between pleural thickening and free fluid.24 
 Interlobar effusion may mimic tumor, occur partially in cardiac failure and 
their clearance following diuretic treatment has given rise to the term vanishing 
tumour.25 
Subpulmonic effusion occurs when pleural fluid accumulates in a subpulmonic 
location. They occur beneath the lung and are often transudates and can be difficult to 
diagnose on the PA radiograph and may requires a lateral decubitus view or 
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ultrasonogram. The PA radiograph will often show a lateral peaking of apparently 
raised hemi- diaphragm which has a steep lateral slope with gradual medial slope. The 
lateral radiograph may have a flat appearance on the posterior aspect of the hemi-
diaphragm with a steep downward at the major fissure.26 
 
PLEURAL FLUID ASPIRATION (THORACOCENTESIS): 
 A diagnostic pleural fluid sample should be collected with a fine bore (21G) 
needle and a 50 ml syringe. The sample should be placed in sterile vials and blood 
culture bottles and analyzed for glucose, protein, LDH, gram stain, AFB stain, 
cytology, microbiological culture. 
 This is the primary means of evaluating pleural fluid and its findings are used 
to guide further investigations. Diagnostic taps are often performed in the clinic or by 
the bed side (if necessary under ultrasound guidance). 
 Microscopic examination of gram stain pleural fluid sediment is necessary for 
all fluids and particularly when a parapneumonic effusion is suspected. If some of the 
microbiological specimen is sent in blood culture bottles the yield is greater, 
especially for anaerobic organisms.27 
 20 ml pleural fluid is  adequate for cytological examination and the fresher the 
sample when it arrives at the laboratory the better is the yield. If the part of the sample 
is clotted, the cytologist must fix and section this and treat it as a histological section 
as it will increase the yield. Sending the cytological sample in a citrate bottle will 
prevent clots and is preferred by some cytologists. If delay is anticipated, the sample 
can be stored at 4oC for up to 4 days.28 
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PERCUTANEOUS PLEURAL BIOPSY:  
 Pleural tissue should always be sent for tuberculosis culture and for histological 
examination whenever a biopsy is performed. Smears for acid fast bacilli are only 
positive in 10 – 20 % of tuberculous effusion and only 25 – 50 % are positive on the 
pleural fluid culture.27, 29  The addition of pleural biopsy histology and culture 
improves the diagnostic rate to about 90%.29 
 Percutaneous pleural biopsies are of greatest value in the diagnosis of 
granulomatous and malignant disease of the pleura. They are performed on patients 
with undiagnosed exudative effusion, with non diagnostic cytology, and clinical 
suspicion of tuberculosis or malignancy.  
Blind percutaneous pleural biopsy is done using an Abram’s needle. The 
Abram’s pleural biopsy needle is most commonly used in the UK while the Cope 
needle is being less commonly used. At least four samples should be taken from a 
single site to optimize diagnostic accuracy, 30 and these should be taken from one site 
as dual biopsy sites do not increase positivity.31, 32 The Biopsy specimens should be 
placed in 10% Formaldehyde for histological examination and sterile saline for 
tuberculosis culture.  
Complications of Abram’s needle pleural biopsy includes, site pain (1-15%), 
pneumothorax (3-15%), vasovagal reactions (1-5%), hemothorax (<2%), Site 
hematoma (<1%), transient fever (<1%) and very rarely death secondary to 
hemorrhage. If a pneumothorax is caused only 1% requires chest drainage.32, 33, 34-37. 
In case of mesothelioma, the biopsy site should be irradiated to stop biopsy site 
invasion by the tumour. 
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PLEURAL FLUID ANALYSIS: 
Key facts when investigating undiagnosed pleural effusion38  
1. If the pleural protein is between 25 and 35 g/L then Light’s criteria are used to 
differentiate accurately exudates from transudates.  
2. Pleural fluid pH should be performed in all non purulent effusions if an infection 
is suspected. 
3. When sending the pleural fluid specimen for microbiological examination, it 
should be sent in both a sterile tube (for Gram Stain, AFB stain and TB culture) 
and in blood culture bottles to increase the diagnostic yield. 
4. Only 60% of malignant effusions can be diagnosed by cytological examination. A 
contrast enhanced CT scan of the thorax is best performed in suspected cases for 
better visualization of pleura and identifying the best site for pleural biopsy. 
5. Grossly bloody pleural fluid is usually due to malignancy, Pulmonary embolus 
with infection, trauma, or Post-cardiac injury syndrome(PCIS). 
Typical characteristics of the pleural fluid: 39  
 After performing pleural aspiration the appearance and odour of the pleural 
fluid should be noted. The unpleasant aroma of anaerobic infection may guide the 
antibiotic choice. The appearance can be divided into serous, blood tinged, frank 
blood, or purulent. If the pleural fluid is turbid or milky it should be centrifuged. If the 
supernatant is clear, the turbid fluid was due to cell debris and empyema is likely. If it 
is still turbid, this is because of high lipid content and a Chylothorax or Pseudo-
chylothorax is likely.42 
A pleural fluid hematocrit is helpful in the diagnosis of Hemothorax. 
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Appearance of pleural fluid: 
                   PLEURAL FLUID             SUSPECTED DISEASE 
                   Putrid odour            Anaerobic Empyema 
                  Food particles            Esophageal rupture 
                  Bile stained            Biliary fistula 
                  Milky            Chylothorax/Pseudochylothorax 
                ‘ Anchovy’ sauce like fluid            Ruptured amoebic abscess 
 
Differentiating between a pleural fluid exudates and transudates: 
 The pleural fluid protein should be measured to differentiate between a 
transudative and exudative pleural effusion. This will usually be suffice if the patients 
serum protein is normal and pleural protein is less than 25 g/L or more than 35 g/L. If 
not, Light’s criteria should be used. 
LIGHT’S CRITERIA: 40 
The pleural fluid is an exudates if one or more of the following criteria are met: 
1. Pleural fluid protein / Serum Protein > 0.5 
2. Pleural fluid LDH / Serum LDH > 0.6 
3. Pleural fluid LDH more than 2/3rd the upper limits of normal Serum LDH 
 The classical way of separating a trasudate from an exudates is by pleural fluid 
protein, with exudates having a protein level of > 30 g/L and transudate  a protein 
level of < 30 g/L. A considerable number of other biochemical markers have been 
compared with Light’s criteria. These include measuring Pleural fluid cholesterol 
albumin gradient42-45 and Serum/Pleural fluid Bilirubin ratio.46  Valdes et al described 
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the ratio between pleural cholesterol to serum cholesterol is more than 0.3 (sensitivity 
92.5%, specificity 87.6%). It is found with 0.4 as the cutoff point the specificity was 
100% and sensitivity 86.04%. 41 
A cut off value of LDH levels in pleural fluid of >0.66, the upper limits of the 
laboratory normal might be a better discriminator ( “Modified Light’s Criteria”).47 
 The weakness of this criteria is that they occasionally identify an effusion in a 
patient with left ventricular failure on diuretics as an exudate. In this circumstance, 
clinical judgement is warranted.  
Differential cell count on the pleural fluid: 48 
 When polymophonuclear cells predominate, the patient has an acute process 
affecting the pleural surfaces. If there is concomitant parenchymal shadowing, the 
most likely diagnoses are parapneumonic effusion and pulmonary embolism with 
infarction. If there is no parenchymal shadowing, then diagnoses are pulmonary 
embolism, viral infection, acute tuberculosis, or benign asbestos pleural effusion.39 
 An eosinophilic pleural effusion is defined as the presence of 10% or more 
eosinophils in pleural fluid. Eosinophilic pleural effusions are not always benign. 
 The presence of pleural fluid eosinophilia is of little use in the differential diagnosis 
of pleural effusions. Benign etiologies include parapneumonic effusion, tuberculosis, 
drug induced pleurisy, benign asbestos pleural effusions,     Churg-Strauss syndrome, 
pulmonary infarction, and parasitic disease.49-51   It is often the result of air or blood in 
the pleural cavity.50  
 If the pleural fluid differential count shows a predominant lymphocytosis, the 
most likely diagnoses are tuberculosis and malignancy. Although high lymphocyte 
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counts in pleural fluid raise the possibility of tuberculous pleurisy, 39 as many as 10% 
of tuberculous pleural effusions are predominantly neutrophilic.48 Lymphoma, 
sarcoidosis, rheumatoid disease, chylothorax can cause a lymphocytic pleural 
effusion.53 
pH  of Pleural fluid:  
 pH should be performed in all cases of purulent effusions. In an infected  
effusion a pH <7.2 indicates the need for tube drainage.54-55 
Glucose: 
 A pleural glucose level of less than 3.3 mmol/L is found in exudative effusions 
secondary to empyema, rheumatoid disease, lupus erythematosis, tuberculosis, 
malignancy, or esophageal rupture.56 The lowest glucose concentrations are found in 
rheumatoid effusions and empyema.56-58 In pleural infection, pH discriminates better 
than glucose.55, 57 Rheumatoid arthritis is unlikely to be the cause of an effusion if the 
glucose level in the fluid is above 1.6 mmol/L.58  
Amylase: 
 Amylase measurement should be requested if acute pancreatitis or rupture of 
the esophagus is suspected. Pleural fluid amylase levels are elevated if they are higher 
than the upper limits of normal for serum or the pleural fluid/ serum ratio is >1.0.59 
This suggests acute pancreatitis, Pseudo cyst of pancreas, esophageal rupture, ruptured 
ectopic pregnancy, or pleural malignancy (especially Adenocarcinoma).39 
Approximately 10% of malignant effusions have a raised pleural amylase levels.60 Iso-
enzyme analysis is useful in differentiating high, amylase levels secondary to 
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malignancy or ruptured oesophagus from those raised in association with abdominal 
pathology. 
 
Cytology: 
 Malignant effusions can be diagnosed by pleural fluid cytology alone in 60% of 
cases. If the pleural fluid cytology specimen is negative, this should be repeated a 
second time. If the malignancy is suspected the cytological examination of the pleural 
fluid is a quick and minimally invasive way to obtain a diagnosis.61-64  
SENSITIVITY OF PLEURAL FLUID CYTOLOGY IN MALIGNANT PLEURAL 
EFFUSION: 
Reference No.of patients No. Of cases caused    
By  malignancy 
%  diagnosed by 
cytology 
Salyer et al62       271          95       72.6 
Prakash et al64       414         162       57.6 
Nancy et al 63       385         109       71.0 
Hirsch61       300         117       53.8 
TOTAL      1370         371       61.6 
 
The yield depends on the skill and interest of the cytologist and on tumour 
type, with a diagnostic rate for adenocarcinoma is more than for mesothelioma, 
squamous cell carcinoma, lymphoma and sarcoma. 
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Staining of pleural fluid          
 A Gram stain of centrifuged pleural fluid should be obtained routinely. Smears 
of pleural fluid for AFB are positive in approximately in 20-30% of patients with 
tuberculous pleurisy (American Thoracic society). 
Adenosine deaminase levels: 
The Adenosine deaminase (ADA) level in pleural fluid tends to be higher with 
tuberculosis than in other exudates.65-66 However, ADA levels are also raised in 
empyema, rheumatoid pleurisy, and malignancy which make the test less useful in 
countries with a low prevalence of tuberculosis.  ADA analysis is a sensitive marker 
of tuberculous pleuritis even in HIV patients with very low CD4 counts in a high TB 
endemic region. The ADA assay is inexpensive, rapid, and simple to perform and   is 
of great value for the immediate diagnosis of tuberculous pleuritis   while waiting for 
culture result and this has a positive impact on patient outcome.  
ADA levels more than 70 IU/L has a sensitivity of 98%, specificity of 96% in 
tuberculous pleural effusion.66  
Other investigations used in the diagnosis of Tuberculous etiology: 
a. Needle biopsy shows 80% cases with demonstration of granuloma. 
b. The level of ADA, Lysozyme, Leukocyte count, lymphocytes in tuberculous 
effusion is higher than that of carcinomatous effusion. 
c. Interferon γ production in tuberculous pleurisy is higher than that of malignant 
effusion. Levels > 140 pg/ml are more in favour of tuberculosis.16  Interleukin-1, 
TNF-α also increased in tuberculous pleural effusion.  
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d. Tuberculous Pleural effusion, detected by tuberculo-stearic acid in pleural 
aspirates has a sensitivity of 71% (Grantham Hospital, Aberdin, Hong-kong). 
e. PCR in the diagnosis of tuberculous pleural effusion is a G-C rich repetitive 
sequence (G=C RS) of mycobacterium tuberculosis that displayed a high 
homology with amplification of the proximal 150 bp of G=C RS and its detection 
by non-radioactive hybridization was developed. The accuracy of G=C RS based 
PCR assay was evaluated in a clinical setting for the detection of mycobacterial 
DNA in pleural fluid for the diagnosis of tuberculosis using clinical criteria and 
pleural biopsy histology as gold standard test. 
 In a blind study, a total of 67 Pleural fluid samples (38 Tuberculous and 29 non 
Tuberculous) were analyzed by PCR and the results were compared with pleural 
biopsy, Zeihl-Neihlson Staining and culture. Mycobacteria could not be detected by 
either smear or culture techniques in any of the pleural fluid samples. Out of  38 
Tuberculous pleural effusion, 24 were positive by PCR (63.2%) histology, an 
increased sensitivity of 73.3% was obtained. Out of the obtained accounting for an 
overall specificity of 93.1 %. G=C RS based PCR assays has a definite role in the 
diagnosis of Tuberculous Pleural effusion in contrast to smear/culture techniques. 
(AIIMS) 
 
ULTRASONOGRAM: 
 Ultrasound guided pleural aspiration should be used as a safe and accurate 
method of obtaining fluid if the effusion is small or loculated. 
 Fibrinous septations are better visualized on ultrasound than on CT Scans. 
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 Ultrasound is more accurate than plain chest radiography for estimating pleural 
fluid volume and aids thoracocentesis.68, 69 
Yang et al 70 found that pleural effusions with complex septations, complex 
non-septations, or homogenously echogenic patterns are always exudates, whereas 
hypo echoic effusions can be either transudates or exudates. Ultrasound is also useful 
in demonstrating fibrinous loculation and readily differentiates between pleural fluid 
and pleural thickening.71  
Recently by using colour Doppler it was observed that numerous echogenic 
floating particles within the pleural effusion (color signal), which is swirled in 
response to respiratory and cardiac cycle (this is Fluid color sign) 71 - is a sign of 
pleural effusion. None of the pleural thickening does not show Fluid color sign 
(specificity 100%). 
 
CT SCAN THORAX: 
 CT Scan for pleural effusion should be performed with contrast enhancement. 
CT scan can usually diferntiate between benign and malignant pleural thickening. 
 In case of difficult drainage, CT scanning should be used to delineate the size 
and position of loculated effusions. 
 These are the features of contrast enhanced thoracic CT scanning which can 
help differentiating in benign and malignant disease Leung et al 73 showed that 
malignant disease is favoured by nodular pleural thickening, mediastinal pleural 
thickening, Parietal pleural thickening greater than 1 cm, and circumferential pleural 
thickening. These features have specificities of 94%, 94%, 88% and 100% and 
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sensitivities of 51%, 36%, 56%, and 41% respectively. When investigating a pleural 
effusion a contrast enhanced thoracic CT scan should be performed before full 
drainage of the fluid as pleural abnormalities will be better visualised.74 
 
THORACOSCOPY: 
 Thoracoscopy should be considered when less invasive tests failed to give a 
diagnosis. Harris et al76  Thoracoscopy over a 5 year period and showed it to have a 
diagnostic sensitivity of 95% for malignancy. 
 
BRONCHOSCOPY:  
 Routine diagnostic bronchoscopy should not be performed for undiagnosed 
Pleural effusion. Bronchoscopy is considered if there is hemoptysis or clinical features 
suggestive of bronchial obstruction. 
 Heaton and Roberts77  bronchoscopy  for undiagnosed pleural effusion has a 
limited role in patients with an undiagnosed pleural effusion.  It should be reserved for 
patients whose radiology suggests the presence of a mass, loss of volume or when 
there is a history of hemoptysis or possible aspiration of a foreign body. 
 
CONNECTIVE TISSUE DISEASES AND PLEURAL EFFUSION: 
Rheumatoid arthritis: 
Suspected cases should have a pleural fluid pH, Glucose and complement 
measured. Rheumatoid arthritis is unlikely to be the cause of an effusion if the glucose 
level in the fluid is above 1.6 mmol/L (29mg/dL). 
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Measurement of C4 complement in pleural fluid may be of additional help, 
with levels below 0.04 g/L in all cases of rheumatoid pleural disease.78 Rheumatoid 
factor can be measured in the pleural fluid and often has a titer of >1:320 
Systemic lupus erythematosis: 
 The pleural fluid ANA level should not be measured as it mirrors serum levels 
and is therefore is unhelpful. The presence of LE cells in pleural fluid is diagnostic of 
SLE, 78,79  Khare et al. 
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MATERIALS AND METHODS 
STUDY PLACE:   
Stanley Medical College & Hospital, Department of Medicine. 
STUDY DURATION:   
Study was done over a period of 18 months, from January 2007 to June2008. 
STUDY POPULATION: 
 Patients admitted with pleural effusion in the department of medicine were 
included in the study. 
STUDY DESIGN: 
 Cross-sectional study. 
INCLUSION CRITERIA: 
1. Any case of Pleural effusion 
2. Age 13-85 years. 
EXCLUSION CRITERIA: 
1. Age < 13 years 
2. Hemodynamically  unstable patients 
3. Pregnant women 
4. Patients with bleeding tendencies. 
METHODOLGY: 
     All patients admitted with pleural effusion in the department of medicine were 
included in the study. All these patients were subjected to detailed clinical history 
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regarding their presenting complaints, other symptoms like breathlessness, chest pain, 
cough with sputum production, fever, weight loss, loss of appetite were enquired. 
Other symptoms of cardiac, liver or renal failure like swelling of feet, abdominal 
distension, oliguria were  also enquired. Past history of any pulmonary tuberculosis, 
any history of previous intake of anti tuberculosis treatment, history of diabetes or any 
other significant illnesses, contact history with tuberculosis were obtained. Detailed 
clinical examination was carried out and routine investigations like Hemoglobin, ESR, 
Mantoux testing were done for all patients. Chest X ray PA view, Lateral decubitus 
view were also taken.  
All the patients were subjected to Diagnostic Pleurocentesis. Under aseptic 
precautions about 10 ml of fluid was aspirated and subjected to pleural fluid analysis – 
Biochemical, Microbiological, Pathological analyses were done. Pleural fluid Sugar, 
Protein, LDH, was  measured for all patients. Pleural fluid ADA levels were estimated 
for exudative effusions in affordable patients. Pleural fluid cell count and cytology 
were done in all patients. Pleural fluid gram staining, AFB staining, Culture and 
sensitivity tests were carried out in all patients. For doubtful cases the Pleural fluid 
biopsy was done and histopathological analysis is carried out. Informed consent was 
obtained for all the invasive procedures prior to it. Pleural Biopsy was done for few 
patients only, due to practical difficulties and many patients deferred to give the 
consent. In our series we used Abram’s pleural biopsy needle for obtaining the pleural 
tissue. Other investigations like Pleural fluid Amylase levels, ANA, Rheumatoid 
factor, Hematocrit were done in those patients with high degree of clinical suspicion 
with the particular disease to support the diagnosis. 
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CT scan thorax was also taken for those affordable patients with clinical 
suspicion of parenchymal lesions or other associated diseases of the lung. Other 
investigations like Echocardiography, Ultra sonogram abdomen were done in relevant 
cases only. Special investigations like Serum ANA, RA factor, CRP, Thyroid function 
tests were done for relevant cases with strong clinical suspicion. All the patients were 
subjected to HIV screening by ELISA technique. All the patients were studied in a 
every possible way and an appropriate etiological diagnosis was made out in a 
systematic way. 
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OBSERVATION AND RESULTS 
SEX RATIO IN THE STUDY: (100 cases) 
 
   
INCIDENCE – AGE/ SEX WISE: (100 cases) 
Age (years) Total no. of cases-100 Male Female 
13-20 7 ( 7%) 4 3 
21-30 23 (23%) 16 7 
31-40 22 (22%) 14 8 
41-50 19 (19%) 15 4 
51-60 14 (14%) 10 4 
61-70 13 (13%) 9 4 
71-80 2 (2%) 2 0 
  
Peak age of incidence of Pleural effusion is between 20-40 y of age. 
 
39 
 
s 
CLINICAL SYMPTOMATOLGY (100 Cases): 
SYMPTOMS FREQUENCY (Cases) 
Dyspnoea 70 
Cough 55 
Fever 54 
Pleuritic chest pain 50 
Anorexia 44 
Weight Loss 37 
Pedal edema 20 
Night sweats 19 
Abdominal distension 12 
Hemoptysis 9 
Abdominal pain 4 
Anasarca 3 
Jaundice 1 
 
PREVIOUS HISTORY OF TUBERCULOSIS: (100 cases) 
 
 
 
 
 
 
TYPE OF TUBERCULOSIS TOTAL MALE FEMALE 
Pleural effusion 2 1 1 
Pulmonary Tb 11 6 5 
Tuberculous abdomen 1 1  
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SIDE OF PLEURAL EFFUSION: (100 cases) 
 
  
EXAMINATION & ANALYSIS OF THE PLEURAL FLUID 
APPEARANCE: (100 cases) 
 
 
 
 
 
 
 
 
PLEURAL FLUID GLUCOSE: 
The mean value of pleural fluid glucose is 69.85 mg/dL and extremely low 
sugar was seen in patients with malignancy and pyogenic infections. 
Appearance of pleural Fluid  No of cases: 
Straw coloured 52 
Clear 20 
High coloured 17 
Pus 5 
Turbid 3 
Hemorrhagic 3 
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PLEURAL FLUID PROTEIN:  (100 cases) 
Exudates                       80 
Transudates                       20 
In all the 20 transudative effusions, the pleural fluid protein/serum protein ratio 
was found to be < 0.5 
In all the 80 exudative effusions, the pleural fluid protein/serum protein ratio 
was found to be > 0.5 
GRAM STAINING AND AFB STAINING: 
None of the cases showed positive results for gram stain and AFB stain 
PLEURAL FLUID CYTOLOGY: 
The cell count varied from 5-120000 cells/cmm in transudative effusion and 
tubercular effusion respectively.  
In 4 cases of malignant pleural effusion the cytology for malignant effusion 
was positive for 2 cases only. 
PLEURAL FLUID CULTURE: 
In 2 cases of pleural effusion bacterial culture was positive- 
       DIAGNOSIS ORGANISM GROWN IN CULTURE 
1. Pyopneumothorax Pseudomonas 
2. Pneumonia/Synpnemonic effusion Klebsiella 
 
PLEURAL FLUID ADENOSINE DEAMINASE LEVELS: 
ADA levels were estimated in 44 cases (41 exudative cases and 3 trasudative 
cases). In Tuberculous effusions the values ranges from 25 – 239 IU/L. The mean 
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ADA level in TB effusion was 123.213 IU/L.  Only 3 cases of TB effusion had their 
values less than 45 IU/L. Only one case of Rheumatoid arthritis had ADA levels of 65 
IU/L.  
PLEURAL BIOPSY:  
Total No. of Pleural Biopsy done 12 
Tuberculous granuloma 6 
Non specific inflammation 5 
Normal study 1 
 
CAUSES OF EXUDATIVE EFFUSION: 
DISEASES No OF CASES 
Tuberculous Pleural effusion 50 
Tuberculous empyema 2 
Tuberculous hydropneumothorax 1 
Pneumonia 8 
Pyogenic pyopneumothorax 2 
Liver abscess 4 
Collagen vascular diseases 4 
Malignancy 4 
Uremia 2 
Pulmonary embolism 1 
Aortic aneurysm 1 
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TUBERCULOUS PLEURAL EFFUSION: 
Sex wise incidence: Tuberculous effusion is more common in males than in females: 
Total no of cases Male Female 
50 39 11 
 
Age wise incidence: Peak incidence of tuberculous pleural effusion is in 21-40 years.  
Age  (yr) Total No of TB effusion-50cases  Male (39)  Female (11) 
14-20 4 2 2 
21-30 17 13 4 
31-40 12 9 3 
41-50 7 7 0 
51-60 6 4 2 
61-70 4 4 0 
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Side of effusion: Right sided effusions are common than the left in Tuberculosis. 
 
Quantity of pleural effusion: 37 cases had moderate effusion. 
  
Risk factors: related to Tuberculous effusion: (total 50 cases) 
Past history of pulmonary tuberculosis 8 
Smoking  22 
Contact with Pulmonary Tuberculosis 11 
Diabetes mellitus 3 
Low socio-economic group 46 
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Clinical features: Symptomatology 
Presenting complaints: Most common symptom at presentation is Pleuritc chest pain. 
Chest pain 20 
Fever 15 
Dyspnoea 10 
Productive cough 2 
Dry cough 1 
Anorexia 1 
Seizures 1 
Frequency of symptoms:(50 cases) Most common symptom is Pleuritic chest pain 
Pleuritic chest pain 35 
Dyspnoea 33 
Fever 32 
Productive cough 25 
Weight loss 25 
Anorexia 25 
Night sweats 15 
Dry cough  9 
Radiological presentation (associated pulmonary parenchymal lesion): 
TB infiltrates  Fibrosis/fibrocavity Cavity 
R L B/L R L B/L R L  B/L 
- 2 1 - 1 - - 1 - 
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TRANSUDATIVE PLEURAL EFUSION: 20 cases 
Transudative causes No of cases 
Cardiac causes-CCF 11 
Liver diseases- DCLD 3 
Nephrotic syndrome 2 
Hypothyroidism 2 
Dengue 1 
Hypoalbuminemia (malabsorption) 1 
 
CARDIAC CAUSES OF PLEURAL EFFUSION: (11 cases) 
Causes  No of cases 
Dilated Cardiomyopathy 4 
Coronary artery heart disease 4 
Rheumatic heart disease/Mitral valve disease 2 
Constrictive pericarditis 1 
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ETIOLOGICAL CAUSES OF PLEURAL EFFUSION in (100 cases): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tuberculosis 53%
 
Pyogenic effusion 9%
 
Liver abscess 4%
Collagen vascular diseases 4%
 
Malignancy 4%
 
Uremia 2%
 
Post-cardiac surgery 2%
 
Pulmonary embolism 1%
 
Aortic aneurysm 1%
 
CCF 11%
 
DCLD 3%
 
Nephrotic syndrome 2%
 
Hypothyroidism 2%
 
Dengue 1%
 
Hypoalbuminemia (Nutritional) 1%
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ETIOLOGICAL CAUSES OF PLEURAL EFFUSION in (100 cases): 
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DISCUSSION 
In our study of 100 cases of pleural effusion, there were 69 males and 31 
females. The patients were in the age group between 13 to 75 years. The mean age of 
the patients was 42 years. The peak age of incidence of overall pleural effusion was 
between 20-40 years. 
 The most common symptom in our series is Dyspnoea (70 %), followed by 
cough (55%), fever (54%), and Pleuritic type of chest pain (in 50% cases). 
Hemoptysis was present in about 9 cases of which 4 were due to Pneumonia, 3 cases 
were due to bronchogenic carcinoma, one case was due to pulmonary infarction and 
one in CCF due to pulmonary congestion. None of the tuberculous pleural effusion did 
not manifest with hemoptysis. 
 Previous history of tuberculosis was elicited in 14 cases. Of which two cases 
were recurrent pleural effusion, 11 were pulmonary tuberculosis and the other one was 
a known Tuberculous abdomen patient. One patient among them  was a treatment 
defaulter. The rest took full course  of anti-tuberculous therapy, 
 The mean Hemoglobin was 10.833 and about 48 cases had their Hemoglobin 
levels below 11g/dL. The nutritional status of the patients in this series was fairly 
well. ESR levels were not much informative in this series and it varied widely from 
and even normal in 10 cases of tuberculous effusion. None of the patients showed 
positivity for HIV ELISA in this study. 
Overall right sided effusions (50%) were more common in our study. Followed 
by left sided effusion in 33% cases and bilateral effusion in 17% cases. Pleural fluid 
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analysis showed that straw coloured fluids were common in 52 % cases followed by 
clear fluid in 20% cases. Hemorrhagic fluid was seen in 3 % cases of pleural effusion 
(hydropneumothorax, carcinoma lung and pulmonary infarction due to pulmonary 
thromboembolism). The cell count varied widely between 5-120000 cells/cmm in 
transudative effusion and tubercular effusion respectively. In 4 cases of malignant 
pleural effusion the cytology was positive in 2 cases only. Most of the cases showed a 
Lymphocyte predominant effusion, in nearly 85 % cases. Polymorphonuclear 
predominant effusions were more common in pyogenic infections. None of the cases 
either tuberculous or pyogenic effusions showed any positivity for gram staining or 
AFB staining. Only two cases showed a positive bacterial culture, one a Pseudomonas 
Pyopneumothorax in an emphysematous patient and a Klebsiella induced syn-
pneumonic pleural effusion. The mean value of pleural fluid glucose was 69.85 mg/dl 
and extremely low sugars were seen in patients with malignancy and pyogenic 
infections. In Rheumatoid arthritis the sugar values were around 30 mg/dl.  
There were about 80 cases of exudative effusion and 20 cases of transudative 
effusion. The pleural fluid protein values ranged from 1.9 g/dl to 8.2 g/dl in exudative 
effusion. About 11 cases had protein values less than 3 g/dl. The mean value of 
Pleural fluid protein was 4.392 g/dl. All these cases had pleural fluid to serum protein 
ratio more than 0.5 and so also the ratio of Pleural fluid LDH to serum LDH was also 
more than 0.6. The rest of the transudative effusions had a protein value less  than   
2.3 g/dl.  
The most common cause of exudative effusion is tuberculous pleural effusion 
(50% cases in our study) 
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TUBERCULOUS PLEURAL EFFUSION: (50%, 50 cases) 
Of the 50 cases, 39 were males and 11 were females. Most of them were 
between 21-40 years of age (29 cases, 58%). The most common symptom at 
presentation is pleuritic chest pain (20 cases, 40%), followed by fever (15 cases, 
30%), dyspnoea (10 cases, 20%). One patient presented with seizures and was found 
to have tuberculoma brain with incidental tuberculous pleural effusion. The most 
common symptoms perceived by the patients were Pleuritic chest pain (70% cases), 
followed by dyspnoea (66%), fever (64%), weight loss and anorexia in 50% cases. 
Night sweats were present in only 30 % cases.  
8 cases of tuberculous pleural effusion had a definite past history of 
tuberculosis, One with TB abdomen, 2 cases with pleural effusion, and the rest all had 
pulmonary tuberculosis. All of them took complete treatment except one defaulter. 11 
cases gave positive contact history with tuberculosis with their family members and 
friends. Out of 50 cases, 22 were chronic smokers. 
Only two patients had an associated bronchial breath sound (cavernous type) 
clinically with end inspiratory crackles. Other three cases had radiologically 
identifiable radio dense infiltrates in the chest X ray. 
Out of the 50 cases only 3 cases were found to be sputum AFB positive and 3 
cases were found to show reactivity for Mantoux test. Right sided (24 cases) effusion 
is common than left sided effusion (22 cases). Most of them had moderate effusion 
and massive effusion was seen in 3 cases (6%) only. Most of them had straw coloured 
pleural fluid on aspiration. The mean protein was about 4.633 g/dl. 49 cases had 
pleural fluid protein >3 g/dl only one patient had a value of about 1.9 g/dl. Pleural 
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fluid ADA levels were estimated in 35 cases of tuberculous effusion. In Tuberculous 
effusions the values ranged from 25 – 239 IU/L. The mean ADA level in TB effusion 
is 123.213 IU/L.  Only 3 cases of TB effusion had their values less than 45 IU/L. 
Pleural Biopsy was done only in 6 patients with suspected tuberculous effusion. All of 
them showed caseating tuberculous granuloma with surrounding area of epitheloid 
cells and lymphocytes. 
In rest of the cases the diagnosis was made on clinical, radiological evidence 
and pleural fluid analysis. Since our resources and facilities are limited, we have not 
done culture for Tubercule bacilli, PCR and Gamma interferon. Tuberculosis is the 
commonest and more prevalent communicable disease in India, a straw coloured fluid 
clots on standing with lymphocytes predominance itself will speak about the 
tuberculous origin. 
Other associated conditions observed with Tuberculous effusion: 
a. 3 cases of pleural effusion had associated pericardial effusion. One case of 
tuberculous empyema had tuberculous pericarditis. The ECG of whom showed 
changes consistent with pericarditis, ST elevation in all the leads & PR 
segment depression. 
b. One case presented with convulsions and later he was evaluated to have 
tuberculoma brain with incidental TB pleural effusion. 
c. 2 cases had associated Tuberculous ascites and one case of cirrhosis of liver 
had a tuberculous effusion. 
d. One case of Liver abscess had biopsy proven tuberculous pleural effusion. 
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e. One case had tuberculous meningoencephalitis presented with alterd sensorium 
and high grade fever along with tuberculous pleural effusion. 
EMPYEMA: (4 cases) 
Empyema secondary to tuberculosis- 2 cases of which one had a tuberculous 
pericarditis with pericardial effusion a 13 year old girl with sputum positive 
pulmonary tuberculosis. 
Other two cases were secondary to liver abscess, probably secondary to rupture 
into thoracic cavity. 
All of them had an acute presentation with classical signs and symptoms. 
SYNPNEUMONIC PLEURAL EFFUSION :( 8%) 
 8 Cases of pleural effusion occurred secondary to pneumonia. All the patients 
were middle aged persons -7 men and one women. All of them had cough with 
sputum production, fever and radiological evidence of consolidation on the  right side 
(5 cases) more when compared to the left.(3 cases). 7 cases had a positive sputum 
culture. Most common organisms were klebsiella and alpha hemolytic streptococci. 
All of them had a high polymorphs count in pleural fluid. Only one had positive 
pleural fluid culture for klebsiella. One patient had a Lung abscess in the left lower 
lobe for which he presented with foul smelling sputum and halitosis. 
PYOGENIC PYOPNEUMOTHORAX: (1%) 
 One case of pyopneumothorax was present. He is a 55 year old male. His 
pleural fluid culture was positive for Pseudomonas. He had associated Emphysema 
which may responsible for the development of pneumothorax. 
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MALIGNANT EFFUSION: (4%) 
Out of 100 cases of pleural effusion malignant effusion was found in 4 cases only 
3 cases were associated with Carcinoma Lung- two being squamous cell carcinoma. 
a.  A 50 year old female presented with chest pain, dyspnoea, hemoptysis, weight 
loss and anorexia. She had a left cervical Lymphadenopathy, L lower lobe 
heterogeneous mass lesion in CT thorax and a left sided moderate pleural 
effusion. Her pleural fluid showed positive cytology for malignant cells. 
Lymph node excision biopsy revealed Metastatic squamous cell carcinoma 
from the lung.  
b. A 75 year old chronic smoker presented with dyspnoea, hemoptysis, weight 
loss , anorexia ,left massive Hydropnuemothorax with right upper lobe Mass 
lesion, Mediastinal mass lesion and mediastinal emphysema. CT guided Lung 
biopsy revealed a poorly differentiated squamous cell carcinoma.  
c. A 69 year old female presented with cough with sputum production, weight 
loss and hemoptysis was evaluated to have Left hemorrhagic pleural effusion 
with a left lower lobe mass lesion invading into the pericardium and presenting 
with large hemorrhagic pericardial effusion. CT guided Lung biopsy of mass 
revealed the lesion as moderately differentiated Grade III Adenocarcinoma. 
d. One another case was an ovarian tumor, a 47 year old female presenting with 
abdominal pain and hypogastric mass. She was found to have ascites, Right 
pleural effusion secondary metastatis to the right side 10th and 11th ribs. USG 
abdomen revealed a mixed echogenic mass in Right adnexa and ascites. Biopsy 
of the abdominal mass   revealed a Papillary serous cystadenocarcinoma. 
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LIVER ABSCESS : (4%) 
 Four cases of Pleural effusion secondary to liver abscess were seen. Of which 
two were frank empyema. All the four had fever and abdominal pain. Presented with 
an exudative effusion. Only one had a positive pleural fluid culture for Pseudomonas. 
UREMIA: (2%) 
 Two cases of pleural effusion, one due to ARF and other due to CKD seen in 
40 year old females. Both of them presented with dyspnoea and volume overload 
signs. Both had exudative effusion with few lymphocytes.  
COLLAGEN VASCULAR DISEASES: (4%) 
 Two cases of Rheumatoid arthritis and two cases of SLE were seen. All the 
four persons were middle aged females. All the four patients had exudative effusion 
and one patient with rheumatoid arthritis had elevated ADA levels and positive RA 
factor in the pleural fluid.Pleural fluid glucose levels were low~30 mg/dl. Right side 
effusions were seen in Rheumatoid arthritis patients whereas bilateral pleural effusion. 
was seen in SLE patients.  
POST CARDIAC SURGERY STATUS: (2 %) 
 Two cases of post-thoracostomy status were seen. A 37 year old female, a 
known Rheumatic Heart disease underwent a closed mitral commisurotomy 1 month 
before the date of admission, was found to have an incidental pleural effusion when 
she was admitted for malarial fever. 
 Other one is 55 year old male, who underwent a CABG 3 months before the 
present admission, admitted for abdominal distension, found to have a minimal left 
pleural effusion, a minimal pericardial effusion. 
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PULMONARY EMBOLISM WITH INFARCTION: (1%) 
 A 30 year old female admitted with sudden onset dyspnoea and chest pain, 
supraventricular tachycardia was found to have a large pulmonary embolism 
occluding the Right main pulmonary artery to lower lobe. Later she developed 
pulmonary infarction with hemorrhagic pleural effusion and hemoptysis. (fig 6 & 7) 
AORTIC ANEURYSM: (1%) 
 A 60 year old male, known Hypertensive with left sided chest pain, palpitations 
and neck pain, was found to have superior mediastinum widening and further 
investigations revealed a large saccular aortic aneurysm of 10.6-6.4 cm size, involving 
the arch of aorta and descending thoracic aorta and eroding the adjacent vertebrae is 
visualized in the CT and MRI study of the thorax.(fig 8 & 9) 
 
Transudative causes:  
 The most common cause of transudative effusion is congestive cardiac failure 
followed by chronic liver disease and nephrotic syndrome. 
CARDIAC DISEASES: (11%)  
 The commonest cause of transudative effusion in our study is due to cardiac 
failure. 11 cases presented with features of cardiac failure and pleural effusion. All the 
cases were above 45 yrs of age except one, a rheumatic heart disease patient who was 
about 19 years of age. Out of 11 cases 8 were male and 3 were female. 6 cases had a 
bilateral pleural effusion, 3 cases presented with right sided effusion and two with left 
sided effusion.  Out of the 11 cases, 4 cases were due to Coronary artery Heart disease 
in whom the ECG changes were consistent with an old Ischemia and 
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Echocardiograohically proven global Hypokinesia with poor ejection fraction. The 
rest 4 cases were due to Dilated Cardiomyopathy, two cases were due to Rheumatic 
Heart disease and one case was due constrictive pericarditis presenting with 
congestive cardiac failure. All the patients had the following common features: 
1. Dyspnoea was present in all the cases. Other common symptoms include orthopnea   
   and paroxysmal nocturnal dyspnoea. 
2. Pedal edema was present in all the cases 
3. JVP was elevated in all the cases, and there were absent a wave in RHD cases with   
   Atrial fibrillation and a prominent y descent in Constrictive pericarditis. 
4. Atrial fibrillation was present in 2 cases of Rheumatic heart disease. 
4. Cardiomegaly was present in 10 cases and pulmonary congestion in 4 cases only. 
5. Congestive hepatomegaly in 6 cases and ascites was present in two cases. 
6. Mild pericardial effusion was present in 2 cases and moderate effusion in one case     
   of constrictive pericarditis.  
7. MR murmur due to LV dysfunction and DCMP was seen in 4 cases, RHD in one  
   case. TR murmur due RVF was seen in 3 cases. 
DECOMPENSATED LIVER DISEASE/CIRHOSIS OF LIVER: (3%) 
 Hepatic hydrothorax was present 3 cases of which 2 were middle aged males 
and the other is a middle aged female. All of them presented with abdominal 
distension, dyspnoea and pedal edema. One patient had Jaundice at the time of 
presentation. All of them had ascites with splenomegaly. SAAG values were>1.1 
mg/dL in all the patients. All of them had cirrhosis of liver with portal hypertension 
and ascites. The causes for cirrhosis include alcoholic liver disease and cryptogenic 
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cirrhosis of liver. One case had a massive pleural effusion and other two had a 
minimal left sided and bilateral effusion respectively. 
NEPHROTIC SYNDROME: (2%) 
 Two cases of nephrotic syndrome presented with facial puffines, pedal edema 
and abdominal distension. One was  a 13 year old male and other a 19 year old 
female. Both of them had a nephrotic range of proteinuria > 3.5 g/day, with a normal 
urea and creatinine levels, with hypercholesterolemia. One patient had a right minimal 
effusion whereas the other had a bilateral pleural effusion. 
HYPOTHYROIDISM: (2%) 
 Two cases of hypothyroidism, one a 57 year old female and other 61 year old 
male, presented with dyspnoea, obesity, constipation were found to have pericardial 
and pleural effusion. In both the cases the TSH levels were elevated > 100mIU/L and 
free T4 and T3 levels were low. 
HYPOALBUMINEMIA: (1%) 
 One case of Hypoalbuminemia was recorded with pleural effusion and ascites 
in a 55 year old female, in whom the serum albumin were 2.1 g/dL and associated 
rheumatic heart disease without any evidence of congestive cardiac failure. She had 
features of abdominal wall edema, pedal edema   malabsorption and her stool 
microscopy revealed Giardia trophozoites. 
DENGUE: (1%)     
One case of dengue fever (24 year, Male) developed a minimal pleural effusion and 
mild ascites which recovered spontaneously without any intervention. 
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RESOLUTION OF PLEURAL EFFUSION80 
 
      Diseases  Incidence      Therapy  Resolution  time 
 
40-90 % 
 
Antibiotics 
 
2-3 weeks 
Parapneumonic effusion a 
Non HIV 
HIV positive 21 % Antibiotics  2-3 weeks 
 
3-23% 
 
 
 
No therapy 
ATT  
ATT + Steroids 
 
2-4 months 
1-2 months 
1-2 months 
Tuberculosis 
Non-HIV 
 
 
HIV positive 3-40% ATT 1-2 months 
Congestive cardiac failure 40-60% Diuretics, ACE-I, Digoxin < 1 month 
PCIS: 
Post Myocardial infarction 
Post pericardiotomy 
Post CABG 
 
40-68% 
41-85% 
40- 90% 
 
NSAIDS, Prednisone 
NSAIDS, Prednisone 
Self limited 
 
1-5 wk (1 wk-4 mo) 
1-3 wk (1 wk-4 mo) 
8 wk (6 wk-20 mo) 
RA 4-7% NSAIDS, Prednisone 3-4 mo (1mo- 5 yr) 
SLE 16-37% Corticosteroids  2 wk (1-6 wk) 
Sarcoidosis 0-7.5% Self limited, Prednisone 1-3 mo (2 wk- 6 mo) 
Pulmonary embolism 10-50% Heparin, LMWH < 1 wk (3-7 days) 
Uremia 2-3% Hemodialysis 4-6 wk 
Pancreatitis 
Acute 
Chronic 
 
4-20% 
5% 
 
Treat acute pancreatitis 
TPN, Thoracocentesis 
 
2 wk (1-8 wk) 
2-3 wk (1-8 wk) 
Benign asbestos effusion 1-9% Self limited 3-4 mo (1-17 mo) 
After organ transplantation 
Lung and heart-lung 
Liver 
 
100% 
50-100% 
 
Self-limited  
Self-limited 
 
2-3 wk (3d –7 mo) 
2-3 wk (3d – 7 mo) 
 
a- Uncomplicated, ATT- anti tuberculous therapy, TPN-Total perenteral nutrition 
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                                            CONCLUSION 
 
 100 cases of pleural effusion admitted in the medical wards of Stanley Medical 
college, Chennai were investigated and the following conclusions were made. 
 
1. The spectrum of etiological  causes ranges from Tuberculosis to 
Hypoalbuminemia 
2. The most common cause of pleural effusion is Tuberculosis (50%) followed by 
congestive cardiac failure (11%) 
3. The peak age of incidence of overall pleural effusion is between 21-40 years. 
The peak age of Tuberculous effusion is between 21-40 years of age. 
4. Most common symptom of overall pleural effusion is Dyspnoea (70%)  
5. Most common symptom of tuberculous pleural effusion is Pleuritic chest pain 
(70 %) followed by Dyspnoea (66%) 
6. Right sided effusions (50%) are more common. 
7. Rare causes of Pleural effusions noted in this study are: 
• Papillary serous cystadenocarcinoma of ovary 
• Pulmonary thromboembolism 
• Collagen vascular diseases-RA and SLE 
• Post cardiac surgery 
• Aortic aneurysm 
• Hypothyroidism 
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NAME  :                                                                                            I.P. NO: 
AGE : 
SEX: 
OCCUPATION:  
ADDRESS: 
 
CLINICAL HISTORY: 
CHEST  PAIN  :                   DUR:                     TYPE:  PLEURITIC/ CONTINUOUS 
BREATHLESSNESS:          DUR:                     CLASS: 
FEVER:                                 DUR:                     LOW GRADE /  HIGH GRADE 
COUGH                                DUR:                     DRY  / PRODUCTIVE 
SPUTUM PRODUCTION:                                 QUANTITY / PURULENT 
HEMOPTYSIS: 
WEIGHT LOSS: 
LOSS OF APPETITE: 
NIGHT SWEATS: 
ORTHOPNEA:                                                     PND: 
SWELLING OF FEETS / FACE: 
ABDOMINAL DISTENSION: 
OLIGURIA: 
JAUNDICE: 
ABDOMINAL PAIN: 
JOINT PAINS / JOINT SWELLING: 
MORNING STIIFNESS: 
RASHES- PHOTOSENSITIVITY: 
TRAUMA TO THE CHEST: 
 
PAST HISTORY: 
TB:                                                               DM: 
ALD/DCLD:                                                                          HT:                    
CKD:                                                                                      CAHD:  
THYROID DISORDERS:                                                    CONTACT  TB : 
OTHERS: ASPIRATION/ GENERAL ANESTHESIA/  EPILEPSY/ COMA 
 
PERSONAL HISTORY: 
      SMOKER   :                          DUR: 
      ALCOHOLIC:                      DUR: 
      EXPOSURE TO STI: 
MENSTRUAL HISTORY:           MENSTRUAL IRREGULARITY: 
 
DRUG INTAKE: 
NITROFURANTOIN/AMIODARONE/ PHENYTION/ METHOTREXATE 
 
CLINICAL EXAMINATION: 
BUILD & NUTRITION: 
FEBRILE / AFEBRILE: 
PALLOR:                                                                ICTERUS: 
LYMPHADENOPATHY:                                     CLUBBING: 
PEDAL EDEMA:  
THYROID: 
EXTERNAL MARKERS OF TUBERCULOSIS: 
EXTERNAL MARKERS OF LIVER DISEASE: 
JVP:  `PULSE:   BP:    R.R.: 
 
EXAMINATION OF RESPIRATORY SYSTEM: 
POSITION OF TRACHEA: 
APICAL IMPULSE: 
CHEST WALL MOVEMENTS: 
VOCAL FREMITUS/VOCAL RESONANCE: 
PERCUSSION: KRONIG ISTHMUS/ TRAUBE’S SPACE OBLITERATION 
                           SHIFTING DULLNESS: 
AUSCULTATION: BREATH SOUNDS / ADDEDSOUNDS 
                                 COIN PERCUSSION/ SUCCUSSION SPLASH 
                                 PLEURAL RUB /   
EXAMINATION OF OTHER ASYSTEMS: 
C.V.S.:                   S3    
ABDOMEN:         HEPATOMEGALY/   ASCITES / SPLENOMEGALY 
C.N.S.:     
                
INVESTIGATIONS:       
1. HB  g/dl :                                                         2.    URINE  :    ALBUMIN: 
T.C.                                                                                            SUGAR : 
            D.C.                                                                                           DEPOSITS: 
            ESR: 
PLATELET COUNT: 
 
3 R.B.S: 
      BLOOD UREA: 
      SERUM CREATININE: 
SERUM ELECTROLYTES:                          Na                   K           
 
4. MANTOUX TEST: 
 
5. CHEST X RAY :                     EFFUSION: MILD / MODERATE / MASSIVE 
PA VIEW: 
LATERAL VIEW: 
DECUBITUS VIEW: 
 
6. ECG: 
 
7. SPUTUM CULTURE & SENSITIVITY: 
 
8. SPUTUM AFB STAINING: 
 
9. LIVER FUNCTION TEST 
TOTAL BILIRUBIN:                  DIRECT:                       INDIRECT: 
SGOT:                                          SGPT:                           ALP: 
TOTAL PROTEIN: 
SERUM ALBUMIN: 
 
10. PLEURAL FLIUD ANALYSIS: 
 
COLOUR:                          STRAW / HEMORRHAGIC/ PUS  
CELL COUNT:                 TOTAL & DIFFERENTIAL COUNT 
CYTOLOGY   : 
BIOCHEMICAL:              SUGAR: 
                                           PROTEIN: 
                                                       LDH:             
            PLEURAL FLIUD/ SERUM PROTEIN RATIO: 
GRAM STAINING: 
ZN STAINING : 
CULTURE & SENSITIVITY: 
ADA: 
SPECIAL INVESTIGATIONS: HEMATOCRIT/TGL/ANA/RA / AMYLASE 
11. PLEURAL BIOPSY: 
 
12. USG: CHEST & ABDOMEN: 
 
13. CT SCAN THORAX  / BRAIN ( IF NEEDED): 
: 
14. ECHOCARDIOGRAPHY:  
 
15. SPECIAL INVESTIGATIONS: 
PERICARDIAL FLUID ANALYSIS: 
ASCITIC FLUID ANALYSIS: 
THYROID FUNCTION TESTS: 
SERUM ANA / RA FCTOR / AMYLASE 
24 HR URINE PROTEINS: 
SPUTUM MALIGNANT CELL CYTOLOGY: 
 
16. .ELISA: 
 
 
FINAL DIAGNOSIS: - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.Right sided Malignant pleural effusion  
                   
 
 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. Left lateral decubitus view, Moderat left sided Pleural effusion 
 
 
 
 
 
ABRAM’ PLEURAL BIOPSY NEEDLE: 
 
Fig 3.     3 piece instrument comprises 8G x 3 1/2" outer cannula with trocar point 
and cutting window which can be closed with a turning action of the inner tube, 
thus catching severed tissue. 
 
   
   COPE’S PLEURAL BIOPSY NEEDLE 
 
 
Fig 4.   Consists of 5 parts, including an 11G outer needle with tapered end and 
an adjustable needle stop. Inner 13G needle has beveled point and fitted stylet. 
Inner 13G biopsy snare has hook shape for sample collection. 
 
 
 
Fig 5. Pleural biopsy specimen  of a  Tuberculous pleural effusion patient 
demonstrating granulomatous inflammation with central caseation. 
 
Fig 8: Aortic aneurysm with Left minimal pleural effusion 
 
 
 
 
 
Fig 9: Large saccular aneurysm 10.6-6.4 cm arch of aorta and  
Descending thoracic aorta aneurysm eroding into the adjacent vertebrae  
With left minimal pleural effusion (MRI thorax) 
 
 
Fig 6 : CT Pulmonary angiography: revealing a Large thrombus occluding 
Rt lower lobe pulmonary artery with Lower lobe pulmonary infarction  
and Rt pleural effusion. 
 
 
Fig 7 : CT thorax of same patient with pulmonary hemorrhagic infarction  
and Rt pleural effusion. 
 
